Flexion Therapeutics Net Profit Margin 2012-2020 | FLXN

Flexion Therapeutics net profit margin from 2012 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Flexion Therapeutics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.08B $-0.14B -175.31%
2020-03-31 $0.08B $-0.15B -174.70%
2019-12-31 $0.07B $-0.15B -202.70%
2019-09-30 $0.06B $-0.16B -261.67%
2019-06-30 $0.05B $-0.16B -362.22%
2019-03-31 $0.03B $-0.17B -534.38%
2018-12-31 $0.02B $-0.17B -743.48%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.519B $0.073B
Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United States. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. Flexion Therapeutics, Inc. is headquartered in Burlington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.063B 42.70
Takeda Pharmaceutical (TAK) Japan $58.420B 10.18
Astellas Pharma (ALPMY) Japan $28.616B 14.50
Eisai (ESALY) Japan $26.691B 22.56
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.675B 24.49
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.291B 43.20
Grifols, S.A (GRFS) Spain $11.489B 14.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.219B 35.69
IPSEN SA ADR (IPSEY) France $8.673B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.656B 12.66
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.795B 43.04
Arrowhead Pharmaceuticals (ARWR) United States $4.533B 0.00
United Therapeutics (UTHR) United States $4.437B 10.26
Evotec AG (EVTCY) Germany $4.033B 140.00
FibroGen (FGEN) United States $3.866B 0.00
Hypermarcas (HYPMY) Brazil $3.572B 13.14
ChemoCentryx (CCXI) United States $3.562B 0.00
Nektar Therapeutics (NKTR) United States $3.226B 0.00
PTC Therapeutics (PTCT) United States $3.140B 0.00
Sage Therapeutics (SAGE) United States $3.061B 0.00
Pacira BioSciences (PCRX) United States $2.438B 64.10
Xencor (XNCR) United States $2.124B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.112B 10.22
Revolution Medicines (RVMD) United States $2.071B 0.00
Corcept Therapeutics (CORT) United States $1.938B 17.85
Cronos Group (CRON) Canada $1.795B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.773B 0.00
USANA Health Sciences (USNA) United States $1.558B 14.68
Ironwood Pharmaceuticals (IRWD) United States $1.513B 10.51
Trillium Therapeutics (TRIL) Canada $1.340B 0.00
Heron Therapeutics (HRTX) United States $1.324B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.145B 10.91
Indivior (INVVY) United States $1.124B 13.93
Karyopharm Therapeutics (KPTI) United States $1.080B 0.00
Esperion Therapeutics (ESPR) United States $1.003B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.993B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Zogenix (ZGNX) United States $0.985B 0.00
Translate Bio (TBIO) United States $0.938B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.872B 543.00
VAXART, INC (VXRT) United States $0.752B 0.00
Endo (ENDP) Ireland $0.694B 1.03
Spectrum Pharmaceuticals (SPPI) United States $0.616B 0.00
Collegium Pharmaceutical (COLL) United States $0.614B 0.00
ImmunoGen (IMGN) United States $0.611B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.606B 0.00
Tilray (TLRY) Canada $0.604B 0.00
Siga Technologies (SIGA) United States $0.547B 58.33
Calliditas Therapeutics AB (CALT) Sweden $0.542B 0.00
Aerie Pharmaceuticals (AERI) United States $0.541B 0.00
Radius Health (RDUS) United States $0.507B 0.00
Molecular Templates (MTEM) United States $0.505B 0.00
Ocular Therapeutix (OCUL) United States $0.492B 0.00
Ardelyx (ARDX) United States $0.474B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
Altimmune (ALT) United States $0.396B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.385B 19.19
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
Organogenesis Holdings (ORGO) United States $0.366B 0.00
TherapeuticsMD (TXMD) United States $0.357B 0.00
Akebia Therapeutics (AKBA) United States $0.353B 0.00
Redhill Biopharma (RDHL) Israel $0.352B 0.00
MEI Pharma (MEIP) United States $0.340B 0.00
DURECT (DRRX) United States $0.331B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.318B 7.88
PROFOUND MEDICL (PROF) Canada $0.317B 0.00
IMV INC (IMV) Canada $0.295B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
Menlo Therapeutics (VYNE) United States $0.272B 0.00
Jounce Therapeutics (JNCE) United States $0.269B 12.73
Aquestive Therapeutics (AQST) United States $0.262B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Rafael Holdings (RFL) United States $0.253B 0.00
Calithera Biosciences (CALA) United States $0.240B 0.00
Lannett Co Inc (LCI) United States $0.234B 5.44
KalVista Pharmaceuticals (KALV) United States $0.228B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.220B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.04
Avadel Pharmaceuticals (AVDL) Ireland $0.188B 0.00
CASI Pharmaceuticals (CASI) United States $0.187B 0.00
Heat Biologics (HTBX) United States $0.184B 0.00
Nivalis Therapeutics (ALPN) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
OptiNose (OPTN) United States $0.174B 0.00
Otonomy (OTIC) United States $0.170B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.135B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.126B 0.00
Champions Oncology (CSBR) United States $0.115B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.107B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.105B 0.00
Aclaris Therapeutics (ACRS) United States $0.103B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
Biomerica (BMRA) United States $0.078B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
CTI BioPharma (CTIC) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.063B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.062B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.052B 0.00
KemPharm (KMPH) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.82
India Globalization Capital (IGC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
IsoRay (ISR) United States $0.037B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.036B 0.00
GTx (ONCT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.81
Opiant Pharmaceuticals (OPNT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.032B 0.00
AgeX Therapeutics (AGE) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Vical (BBI) United States $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Sundial Growers (SNDL) Canada $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.015B 23.27
Flex Pharma (SLRX) United States $0.015B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00